• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Obstetrics

Rates of neurodevelopmental impairment unchanged in infants born ≤500g in Japan

byMatthew Lin, MDandCordelia Ross
November 16, 2018
in Obstetrics, Pediatrics
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

The rate of neurodevelopmental impairment (NDI) in infants born ≤500g in Japan between 2003-2012 was 59%, and the prevalence of NDI did not significantly change over the 10-year period.

Evidence Rating Level: 1 (Excellent)

Study Rundown: Survival rates for periviable infants have improved over the past decade, but data on rates of neurodevelopmental disabilities in this population vary by study. Accurate data on long-term neurodevelopmental outcomes is critical for families and physicians to make informed decisions regarding resuscitation and care of these infants. The purpose of this study was to describe 3-year neurodevelopmental outcomes in infants born ≤500g registered in the Neonatal Research Network of Japan (NRNJ). The overall rate of NDI in this cohort was 59%, while rates of cerebral palsy (CP), visual impairment, hearing impairment, and cognitive impairment were 22.2%, 21.3%, 4.3%, and 48.2%. There were no significant changes in the prevalence of NDI and no disability over the 10-year study period. NDI was also significantly associated with cystic periventricular leukomalacia (cPVL), severe necrotizing enterocolitis (NEC), patent ductus arteriosus (PDA) ligation, and male sex. GA and BW were not associated with a higher adjusted risk ratio (aRR) of NDI. Limitations of this study included a homogenous population, attrition (which may have reduced power to detect the effects of GA or BW on NDI), and lack of comparison to term born infants. Data from this study should prompt targeting white matter injuries in perinatal medicine to improve developmental outcomes.

Click to read the study, published today in Pediatrics

Relevant Reading: Early mortality and morbidity in infants with birth weight of 500 grams or less in Japan

In-Depth [prospective cohort]: Out of 1613 infants ≤500g registered in the NRNJ, 460 (56.7%) had follow-up data at 36-42 weeks for analysis. Exclusion criteria included death in the delivery/operating room, transfer to outside hospital, GA <22 weeks, and unavailable mortality records during NICU stay. Median GA was 24 6/7 weeks (range = 22 0/7-33 2/7) and median BW was 462g (range = 267-500g). Primary outcomes included NDI, defined as CP, visual or hearing impairment, or cognitive impairment. Cognitive impairment was defined as a developmental quotient (DQ) score of <70 using the Kyoto Scale of Psychological Development. The proportions of NDI, CP, visual impairment, hearing impairment, and cognitive impairment in the entire cohort were was 59.1% (95%CI =54.6-63.5%), 22.2% (95%CI =54.6-63.5), 21.3% (95%CI =17.7-25.3), 4.3% (95%CI =2.7-6.8%), and 48.2 (95% CI =43.5-52.8%), respectively. Overall, 80 children (17.4%) had no disability. The study group was also stratified into 2 weight groups: ≤400 (n=65) and 401-500g (n=395). There were no significant differences in rates of NDI between the 2 groups, but cognitive impairment was significantly higher in the ≤400g group compared to the 401-500g group (60.7% versus 46.2, P = 0.04). NDI and no disability remained unchanged in their prevalence (P=0.70 and 0.78, respectively) over the 10-year study period. NDI was significantly associated with severe IVH (aRR=1.42, 95%CI =1.19-1.68, P <0.01), cPVL (aRR =1.40, 95%CI =1.13-1.73, P <0.01), severe NEC (aRR =1.31, 95%CI =1.07-1.60, P <0.01), PDA ligation (aRR=1.29, 95%CI =1.09-1.54, P <0.01), and male sex (aRR =1.19, 95%CI =1.01-1.40, P=0.04) in multivariate regression analysis.

Image: PD

RELATED REPORTS

Nasal high-flow therapy improves likelihood of neonatal intubation

Noninvasive ventilation with neurally adjusted ventilatory assist (NIV-NAVA) outperforms nasal continuous positive airway pressure (NCPAP) post-extubation in preterm infants

Antenatal corticosteroids may affect neurodevelopment differently based on gestational age

©2018 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

 

Tags: developmental delaydevelopmental pediatricsneonatal intensive care unit (NICU)neonatologyneurodevelopmentpediatric care
Previous Post

Quick Take: Long-Term Survival of Patients With Melanoma With Active Brain Metastases Treated With Pembrolizumab on a Phase II Trial

Next Post

Quick Take: Sex differences in risk factors for myocardial infarction: cohort study of UK Biobank participants

RelatedReports

Low evidence for glycerin use in preterm infants
Obstetrics

Nasal high-flow therapy improves likelihood of neonatal intubation

May 13, 2022
No decrease in infant mortality with maternal micronutrient supplementation in Bangladesh
Pediatrics

Noninvasive ventilation with neurally adjusted ventilatory assist (NIV-NAVA) outperforms nasal continuous positive airway pressure (NCPAP) post-extubation in preterm infants

May 6, 2022
Abusive head trauma results in fewer productive life-years
Chronic Disease

Antenatal corticosteroids may affect neurodevelopment differently based on gestational age

April 28, 2022
Oophorectomy associated with reduced cancer risk and all-cause mortality for BRCA1/2 patients
Genetics

Rapid genotyping for variant associated with aminoglycoside-induced ototoxicity is feasible in acute neonatal setting

April 6, 2022
Next Post
Using HEART score to risk stratify patients with chest pain is safe but underutilized in the ED

Quick Take: Sex differences in risk factors for myocardial infarction: cohort study of UK Biobank participants

Disparities exist in economic impact of childhood food allergy

Policy statement outlines recommendations to improve understanding of pediatric global health issues

Parental cannabis use increasing, cigarette use decreasing

Marijuana exposure common in children of tobacco smokers

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

Get 2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Mediterranean diet superior to low-fat diet in secondary prevention of cardiovascular events
  • Early onset Lewy Body Dementia is more clinically distinct from Alzheimer Dementia than late onset Lewy Body Dementia
  • Pelvic lymph node radiotherapy and androgen deprivation therapy augment progression-free status following prostatectomy
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.